glutathione nasal spray parkinson& 39 - Immunity & Detox Experimental nasal spray could slow
Experimental nasal spray could slow Parkinson's progression, FIU researchers say a breakthrough may be within 5 years CBS Miami Central nervous system uptake of intranasal glutathione in Parkinson's disease npj Parkinson's Disease Nose to brain drug delivery: from bench to bedside PMC A Preclinical Model for Parkinson's Disease Based on Transcriptional Gene Activation via KEAP1 NRF2 to Develop New Antioxidant Therapies Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rationale, Successes, and Future Needs CNS Drugs Springer Nature Link Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease ScienceDirect
Pay in 4 interest-free payments of $7.24 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




